Aerobid Related Published Studies
Well-designed clinical trials related to Aerobid (Flunisolide Inhalation)
Intranasal flunisolide treatment in children with adenoidal hypertrophy. [2007.10]
Inhaled flunisolide suppresses the hypothalamic-pituitary-adrenocortical axis, but has minimal systemic immune effects in healthy cats. [2006.01]
A randomized controlled trial of inhaled flunisolide in the management of acute asthma in children. [2003.09]
Comparison of high-dose inhaled flunisolide to systemic corticosteroids in severe adult asthma. [2002.10]
Multiple-dose proportionality study of flunisolide hydrofluoroalkane. [2002.09]
One-year trial on safety and normal linear growth with flunisolide HFA in children with asthma. [2002.06]
Single-dose study to compare the pharmacokinetics of HFA flunisolide and CFC flunisolide. [2002.02]
Flunisolide HFA vs flunisolide CFC: pharmacokinetic comparison in healthy volunteers. [2001.12]
Effective control of asthma with hydrofluoroalkane flunisolide delivered as an extrafine aerosol in asthma patients. [2001.11]
Suppression of hypothalamic-pituitary-adrenal axis activity with inhaled flunisolide and fluticasone propionate in adult asthma patients. [2001.11]
Deposition and pharmacokinetics of flunisolide delivered from pressurized inhalers containing non-CFC and CFC propellants. [2001.06]
Randomized trial of inhaled flunisolide versus placebo among asthmatic patients discharged from the emergency department. [2000.11]
Pharmacokinetics of flunisolide administered via metered dose inhaler with and without a spacer device and following oral administration. [2000.05]
Exhaled nitric oxide in asthmatic children exposed to relevant allergens: effect of flunisolide. [2000.04]
Comparison of efficacy and safety between flunisolide/AeroChamber and budesonide/turbuhaler in patients with moderate asthma. AER-MD-04 Study Group. [2000.03]
Cost effectiveness of fluticasone propionate and flunisolide in the treatment of corticosteroid-naive patients with moderate asthma. [1999.11]
A controlled study on the effectiveness of loratadine in combination with flunisolide in the treatment of nonallergic rhinitis with eosinophilia (NARES). [1999.08]
Effects of the inhaled corticosteroids fluticasone propionate, triamcinolone acetonide, and flunisolide and oral prednisone on the hypothalamic-pituitary-adrenal axis in adult patients with asthma. [1999.02]
Lung deposition of fenoterol and flunisolide delivered using a novel device for inhaled medicines: comparison of RESPIMAT with conventional metered-dose inhalers with and without spacer devices. [1998.04]
Inhaled flunisolide for acute severe asthma. [1998.03]
Effects of low and high doses of inhaled flunisolide and triamcinolone acetonide on basal and dynamic measures of adrenocortical activity in healthy volunteers. [1998.03]
Six-week trial of nebulized flunisolide nasal spray: efficacy in young children with moderately severe asthma. [1997.12]
Allergic rhinitis in children: effects of flunisolide and disodium cromoglycate on nasal eosinophil cationic protein. [1997.03]
The effectiveness of once-daily dosing of inhaled flunisolide in maintaining asthma control. [1997.03]
[Controlled clinical comparative evaluation of fluticasone powder inhalation versus flunisolide dose aerosol in patients with mild to moderate asthma] [1997.01]
Efficient delivery to the lungs of flunisolide aerosol from a new portable hand-held multidose nebulizer. [1996.09]
New formulation of aqueous flunisolide nasal spray in the treatment of allergic rhinitis: comparative assessment of safety, tolerability, and efficacy. [1996.05]
Nebulized flunisolide in infants and young children with asthma: a pilot study. [1996.05]
Comparative trial of acceptability of beclomethasone dipropionate and a new formulation of flunisolide. [1994.06]
Intranasal flunisolide spray as an adjunct to oral antibiotic therapy for sinusitis. [1993.12]
Comparative taste evaluation of aerosolized formulations of triamcinolone acetonide, flunisolide, and flunisolide with menthol. [1993.11]
Double-blind evaluation of effectiveness and safety of flunisolide aerosol for treatment of bronchial asthma in children. [1990.11]
[Clinico-functional evaluation of flunisolide + salbutamol combination (VAL 679/A) vs salbutamol in pediatric patients] [1990.06]
Evaluation of symptom relief, nasal airflow, nasal cytology, and acceptability of two formulations of flunisolide nasal spray in patients with perennial allergic rhinitis. [1990.06]
Beclomethasone dipropionate versus flunisolide as topical steroid treatment in patients with perennial rhinitis. [1989.10]
Comparative tolerability of two formulations of Rhinalar (flunisolide) nasal spray in patients with seasonal allergic rhinitis. [1988.10]
Well-designed clinical trials possibly related to Aerobid (Flunisolide Inhalation)
Intranasal corticosteroids for nasal airway obstruction in children with moderate to severe adenoidal hypertrophy. [2008.07.16]
Relative oral corticosteroid-sparing effect of 7 inhaled corticosteroids in chronic asthma: a meta-analysis. [2008.07]
Effects of drug treatment on inflammation and hyperreactivity of airways and on immune variables in cats with experimentally induced asthma. [2005.07]
Comparison of patient preference and ease of teaching inhaler technique for Pulmicort Turbuhaler versus pressurized metered-dose inhalers. [2004.06]
[Therapeutic effect of the association between pulmonary ventilation and aerosol--inhalation with sulphureous mineral water in the chronic bronchopneumopathies] [2004.04]
Asthma steroid pharmacogenetics: a study strategy to identify replicated treatment responses. [2004]
Effect of topical nasal corticosteroids on patients with chronic fatigue syndrome and rhinitis. [2003.09]
Triple inhaled drug protocol for the treatment of acute severe asthma. [2003.06]
Fluticasone propionate 100 microg bid using a non-CFC propellant, HFA 134a, in asthmatic children. [2003.03]
Systemic effect comparisons of six inhaled corticosteroid preparations. [2002.05.15]
A comparison of methods for assessing hypothalamic-pituitary-adrenal (HPA) axis activity in asthma patients treated with inhaled corticosteroids. [2002.03]
Corticosteroids administered by nebulization to children with bronchial asthma. [2001.11]
Efficacy of a steroid nasal spray compared with an antihistamine nasal spray in the treatment of perennial allergic rhinitis. [2000.07]
Effectiveness and acceptability of a domiciliary multidrug inhalation treatment in elderly patients with chronic airflow obstruction: metered dose inhaler versus jet nebulizer. [2000.03]
A bioassay for topical and systemic effect of three inhaled corticosteroids. [1995.04]
Rhinomanometric evaluation of two nasal steroid sprays in rhinitis. [1989.10]
Experimentally induced nasal allergic responses. [1988.05]
Other research related to Aerobid (Flunisolide Inhalation)
A reappraisal of the clinical efficacy of nebulized flunisolide in pediatric asthma: the Italian experience. [2007.11]
Strength and endurance of the respiratory and handgrip muscles after the use of flunisolide in normal subjects. [2007.07]
Strength and endurance of the respiratory and handgrip muscles after the use of flunisolide in normal subjects. [2007.05.15]
Efficacy of nebulized flunisolide combined with salbutamol and ipratropium bromide in stable patients with moderate-to-severe chronic obstructive pulmonary disease. [2006]
Flunisolide decreases exhaled nitric oxide and nitrotyrosine levels in asthmatic children. [2006]
Efficacy of Nebulized Flunisolide Combined with Salbutamol and Ipratropium Bromide in Stable Patients with Moderate-to-Severe Chronic Obstructive Pulmonary Disease. [2005.11.15]
Evidence of remodeling in peripheral airways of patients with mild to moderate asthma: effect of hydrofluoroalkane-flunisolide. [2005.11]
Enhanced anti-inflammatory potency of a nitric oxide-releasing derivative of flunisolide: role of nuclear factor-kappaB. [2004.09]
Flunisolide HFA for the treatment of asthma: an old friend reformulated. [2004.05]
Effect of HFA-flunisolide on peripheral lung inflammation in asthma. [2003.07]
Evaluation of efficacy and safety of flunisolide hydrofluoroalkane for the treatment of asthma. [2003.03]
The output of flunisolide from different nebulisers. [2002.04]
Flunisolide HFA. [2002]
Effect of an inhaled glucocorticoid, flunisolide, on bone mineral density: a 2-year prospective, controlled trial. [2000.07]
Comparison of the efficacy of inhaled fluticasone propionate, 880 microg/day, with flunisolide, 1500 microg/day, in moderate-to-severe persistent asthma. [1999.10]
Evaluation of bone metabolism after the use of an inhaled glucocorticoid (flunisolide) in patients with moderate asthma. [1999.07]
Pharmacokinetic/pharmacodynamic evaluation of systemic effects of flunisolide after inhalation. [1997.10]
Comparison of topical silver nitrate and flunisolide treatment in patients with idiopathic non-allergic rhinitis. [1996.06]
Treatment of idiopathic pulmonary hemosiderosis with inhaled flunisolide. [1995.09]
[Effect of flunisolide on exacerbation of clinical symptoms, spirometric parameters, consumption of B2-adrenergic drugs and levels of cortisol and ECP in serum of patients with bronchial asthma] [1995]
[Efficacy of flunisolide in treatment of patients with bronchial asthma] [1995]
[Evaluation of one month treatment with flunisolide in perennial allergic rhinitis] [1995]
[Eight-year long study of the usage of flunisolide (syntaris) at the Otolaryngological clinic at the Warsaw Academy] [1994]
[Clinical and rhino-manometric evaluation of flunisolide in treatment of seasonal allergic rhinitis] [1994]
Inhibitory effects of inhaled flunisolide on inflammatory functions of alveolar macrophages. [1993]
Clinical observations of nebulized flunisolide in infants and young children with asthma and bronchopulmonary dysplasia. [1992.08]
Effect of flunisolide on nasal eosinophils and IgE, and symptom score in children with allergic rhinitis. [1992.07]
Topical flunisolide treatment of perennial rhinitis: clinical and immunological effects. [1992.05]
A comparison of the effects of bid and qid dosing on compliance with inhaled flunisolide. [1992.02]
Topical flunisolide treatment of perennial rhinitis: clinical and immunological effects. [1991.09]
[Development of a spacer for inhaled corticosteroid. Evaluation using flunisolide metered dose aerosol] [1991.01.15]
[Cytological examination of nasal discharge before and after local administration of flunisolide (syntaris)] [1990]
In vitro effect of beclomethasone dipropionate and flunisolide on the mobility of human nasal cilia. [1987.10]
Other possibly related research studies
Poor sleep and daytime somnolence in allergic rhinitis: significance of nasal congestion. [2002]
Nasal cellularity in 183 unselected schoolchildren aged 9 to 11 years. [2002.12]
Intranasal corticosteroids versus topical H1 receptor antagonists for the treatment of allergic rhinitis: a systematic review with meta-analysis. [2002.11]
Therapeutic significance of distal airway inflammation in asthma. [2002.02]
Cost analysis of the use of inhaled corticosteroids in the treatment of asthma: a 1-year follow-up. [2001.12]
An interactive algorithm for the assessment of cumulative cortisol suppression during inhaled corticosteroid therapy. [2000]
Improved asthma control after changing from low-to-medium doses of other inhaled corticosteroids to low-dose fluticasone propionate. [2001.06.08]
Pharmacokinetics of intranasal corticosteroids. [2001.07]
e-NO peak versus e-NO plateau values in evaluating e-NO production in steroid-naive and in steroid-treated asthmatic children and in detecting response to inhaled steroid treatment. [2001.01]
Systemic effects of intranasal steroids: an endocrinologist's perspective. [2000.10]
The effect of inhaled steroids on the linear growth of children with asthma: a meta-analysis. [2000.07]
Aerosol characterization of three corticosteroid metered dose inhalers with volumatic holding chambers and metered dose inhalers alone at two inspiratory flow rates. [1999.01]
[Modes of administration of inhaled corticosteroids in mild to moderate persistent asthma] [1999.11]
Gastroesophageal reflux in infants with wheezing. [1999.09]
Effects of high-dose inhaled corticosteroids on plasma cortisol concentrations in healthy adults. [1999.09.13]
|
